Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UroGen Pharma (URGN) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for UroGen Pharma (URGN) over the last 6 years, with Dec 2024 value amounting to $2.9 million.

  • UroGen Pharma's Amortizatization of Intangibles fell 93.02% to $160,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 95.02%. This contributed to the annual value of $2.9 million for FY2024, which is 179.59% up from last year.
  • According to the latest figures from FY2024, UroGen Pharma's Amortizatization of Intangibles is $2.9 million, which was up 179.59% from $1.0 million recorded in FY2023.
  • Over the past 5 years, UroGen Pharma's Amortizatization of Intangibles peaked at $2.9 million during FY2024, and registered a low of $942,000 during FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $1.8 million (2022), whereas its average is $1.9 million.
  • Per our database at Business Quant, UroGen Pharma's Amortizatization of Intangibles plummeted by 42.14% in 2021 and then skyrocketed by 179.59% in 2024.
  • Yearly analysis of 5 years shows UroGen Pharma's Amortizatization of Intangibles stood at $1.6 million in 2020, then slumped by 42.14% to $942,000 in 2021, then surged by 86.20% to $1.8 million in 2022, then plummeted by 41.05% to $1.0 million in 2023, then spiked by 179.59% to $2.9 million in 2024.